Feature

Long COVID: ‘On par’ with heart disease, cancer, book says


 

Altmann: “I completely agree. If you go to a website, like clinicaltrials.gov, you’ll find an immense number of clinical trials on COVID. There isn’t really a shortage of them, some of them better-powered to get an answer than others.”

How do you think public policy needs to adapt for long COVID, including social safety nets such as workers’ compensation and disability benefits?

Medinger: “In terms of public policy, what I would like would be some public acknowledgment that it’s real from government sources. Just the acknowledgment that it’s real and it remains a risk even now.”

Altmann: “Nobody in politics asks my opinion. I think they’d hate to hear it. Because if I went to see them and said, well, actually, if you thought the COVID pandemic was bad, wait till you see what’s on the table now. We’ve created a disabled population in our country of 2 million, at least a portion if not more of people who are not fully contributory to the workforce anymore ... [with] legal wrangles about retirement and health insurance and pensions, and a human right to adequate health care. Which means, ideally, a purpose-built clinic where they can have their respiratory opinion and their rheumatology opinion and their endocrine opinion and their neurology opinion, all under one roof.”

You’ve both shown so much optimism. Why is that?

Altmann: “I’ve been an immunologist for a long time now, and written all my decades of grant applications, where as a community we made what, at the time, were kind of wild promises and wildly optimistic projections of how our knowledge of tumor immunity would revolutionize cancer care, and how knowledge of autoimmunity would revolutionize care of all the autoimmune diseases.

And weirdly almost every word we wrote over those 25 or 30 years came true. Cancer immunotherapy was revolutionized, and biologics for diabetes, multiple sclerosis, and arthritis were revolutionized. So if I have faith that those things came true, I have complete faith in this as well.”

Medinger: “From the patient perspective, what I would say is that we are seeing people who’ve been ill for more than 2 years recover. People are suddenly turning the corner when they might not have expected to.

And while we don’t quite know exactly why yet, and it’s not everyone, every single time I hear the story of someone saying, ‘I’m pretty much back to where I was, I feel like I’ve recovered,’ I feel great. Even if I haven’t. Because I know that every single time I hear someone say that, that just increases the probability that I will, too.”

A version of this article first appeared on WebMD.com.

Pages

Recommended Reading

Q&A with long COVID patient-researcher: Treatments lagging as cases rise
Journal of Clinical Outcomes Management
Long COVID affecting more than one-third of college students, faculty
Journal of Clinical Outcomes Management
Inflammation and immunity troubles top long-COVID suspect list
Journal of Clinical Outcomes Management
Metformin linked to reductions in COVID-19 viral load
Journal of Clinical Outcomes Management
Is cellular senescence related to post–COVID-19 syndrome?
Journal of Clinical Outcomes Management
Even mild COVID is hard on the brain
Journal of Clinical Outcomes Management
‘Breakthrough’ study: Diabetes drug helps prevent long COVID
Journal of Clinical Outcomes Management
COVID raises risk for long-term GI complications
Journal of Clinical Outcomes Management
COVID can mimic prostate cancer symptoms
Journal of Clinical Outcomes Management
Long COVID hitting some states, minorities, women harder
Journal of Clinical Outcomes Management